Form 4 for EW Edwards Lifesciences
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-14 · accession 0001225208-25-001751 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-14 | 2025-02-14 | EW | LORANGER STEVEN R | Dir | M - OptEx | $45.32 | +5,739 | 66.1K | +10% | +$260.1K |
| D | 2025-02-14 | 2025-02-14 | EW | LORANGER STEVEN R | Dir | S - Sale+OE | $76.42 | -5,739 | 60.4K | -9% | -$438.6K |
| D | 2025-02-14 | 2025-02-14 | EW | LORANGER STEVEN R | Dir | M - OptEx | $0.00 | -5,739 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | M | A | 5,739 | $45.32 | 66,111 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | S | D | 5,739 | $76.42 | 60,372 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $76.400 to $76.435. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Director Stock Option (Right to Acquire) | 2025-02-14 | M | D | 5,739 | $0.00 | 0 | D | $45.32 · 2018-05-18 to 2025-05-17 | 5,739 Common Stock |